New Therapies Targeting apoB Metabolism for High-Risk Patients with Inherited Dyslipidaemias: What Can the Clinician Expect?
Year: 2013
Type: review
Source: Cardiovascular Drugs and Therapy
Authors: Amirhossein Sahebkar, Gerald F. Watts
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2081678895
